High Speed Genetic Testing Technology and the Computerization of the Medical Record

  • Curtis R. Naser


The Human Genome Project—a three billion dollar, fifteen year effort to map and sequence the human genome1—was begun in 1990 and is presently estimated to be ahead of schedule. The base-pair by base-pair sequencing of the entire three billion bases of the human genome is within reach within the next five years. The phenomenal success of the project in meeting and surpassing its goals is largely due to advances in sequencing technologies and informatics. Indeed, the standard genomic sequencing technologies are largely automated and computer assisted (Gibbs, 1995). In addition, the analysis of raw genetic sequence, and its integration with maps of the various chromosomes is largely a project in informatics, the results of which are freely available over the World Wide Web. The purposes of this massive, industrial strength science project, are manifold. Besides providing the building blocks for answering questions about the ontogeny of the human organism, how the human species has diverged both from its evolutionary precursors as well as how individual races and ethnic groups have diverged genetically2, the Human Genome Project promises to revolutionize the practice of medicine and is already revolutionizing the strategies of biomedical research (Watson, 1992).3 It is this latter promise that is probably the most compelling reason that the United States Congress was willing to invest $200 million a year in this project.


Genetic Testing Genetic Information Medical Genetic Human Genome Project Manage Care Organization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anderson, C. (1993), ‘Genome Project Goes Commercial. [News]’, Science, Vol. 259,No. 5093, 15 Jan, pp. 300–302.PubMedCrossRefGoogle Scholar
  2. Annas, G.J. (1990), ‘Outrageous Fortune: Selling Other People’s Cells’, Hastings Center Report, Vol. 20,No. 6, pp. 36–39.PubMedCrossRefGoogle Scholar
  3. Annas, George J. (1993), ‘Privacy Rules for DNA Databanks: Protecting Coded ‘Future Diaries’’, Journal of the American Medical Association, Vol. 270,No. 19, 17 November, pp. 2346–2350.PubMedCrossRefGoogle Scholar
  4. Annas, George J.; Glantz, Leonard H.; Roche, Patricia A. (1995), ‘The Genetic Privacy Act and Commentary’ Boston University School of Public Health, Boston.Google Scholar
  5. Anonymous (1996), ‘Gene Donors’ Rights at Risk’, Nature, Vol. 381, p. 1.Google Scholar
  6. Anonymous (1996), ‘Capitalizing on the Genome [editorial]’, Nature Genetics, Vol. 13,No. 1, May, pp. 1–5.CrossRefGoogle Scholar
  7. Capron, Alexander M. (1991), ‘Protection of Research Subjects: Do Special Rules Apply in Epidemiology?’, Journal of Clinical Epidemiology, Vol. 44, pp. 81s–89s.PubMedCrossRefGoogle Scholar
  8. Clarke, Angus (1991), ‘Is Non-directive Genetic Counseling Possible?’, Lancet, Vol. 338, pp. 998–1001.PubMedCrossRefGoogle Scholar
  9. Cook-Deegan, R. (1994), ‘The Gene Wars: Science, Politics, and the Human Genome Project’ W. W. Norton, New York.Google Scholar
  10. Dahm, Lisa L. (1997), ‘Using the DNA Profile as the Unique Patient Identifier in the Community Health Information Network: Legal Implications’, The John Marshall Journal of Computer & Information Law, Vol. 15,No. 2, Winter, pp. 227–275.Google Scholar
  11. Decruyenaere, Marleen; Evers-Kiebooms, Gerry; Van den Berghe, Herman (1993), ‘Perception of Predictive Testing for Huntington’s Disease by Young Women: Preferring Uncertainty to Certainty?’, Journal of Medical Genetics, Vol. 30, pp. 557–561.PubMedCrossRefGoogle Scholar
  12. Drmanac, Radoje; Labat, Ivan; Brukner, Ivan; Crkvenjakov, Radomir (1989), ‘Sequencing of Megabase Plus DNA by Hybridization: Theory of the Method’, Genomics, Vol. 4, pp. 114–128.PubMedCrossRefGoogle Scholar
  13. Edelstein, Ludwig (1943), ‘The Hippocratic Oath: Text, Translation and Interpretation’, Supplement to the Bulletin of the Histoiy of Medicine, Vol. 1, p. 3.Google Scholar
  14. Fersko, R.S.; Connolly, M.J. (1992), ‘Intellectual Property Issues in a Clinical Trial: A Corporate Perspective’, Quality Assurance, Vol. 1,No. 3, June, pp. 237–248.PubMedGoogle Scholar
  15. Fisher, Lawrence M. (1996), ‘Cancer-Research Venture Announced’, New York Times, 21 August, p. C6.Google Scholar
  16. Fodor, Stephen P.A.; Read, J.Leighton; Pirrung, Michael C; Stryer, Lubert; Lu, Amy Tsai; Solas, Dennis (1991), ‘Light-Directed, Spatially Addressable Parallel Chemical Synthesis’, Science, Vol. 251, pp. 767–773.PubMedCrossRefGoogle Scholar
  17. Giardiello, Francis M.; Brensinger, Jill D.; Brensinger, Jill D.; Peterson, Gloria M.; et al. (1997), ‘The Use and Interpretation of Commercial APC Gene Testing for Familial Adenomatous Polyposis’, The New England Journal of Medicine, Vol. 336,No. 12, 20 March, pp. 823–827.PubMedCrossRefGoogle Scholar
  18. Gibbs, Richard A. (1995), ‘Pressing Ahead with Human Genome Sequencing’, Nature Genetics, Vol. 11,No. 2, October, pp. 121–125.PubMedCrossRefGoogle Scholar
  19. Gilbert, Walter (1992), ‘A Vision of the Grail’ Kevles; in Hood, Daniel J. Leroy (ed.), The Code of Codes: Scientific and Social Issues in the Human Genome Project Harvard University Press, Cambridge, pp. 83–97.Google Scholar
  20. Greely, Henry T. (1995), ‘Conflicts in the Biotechnology Industry’, Journal of Law, Medicine and Ethics, Vol. 23,No. 4, Winter, pp. 354–359.CrossRefGoogle Scholar
  21. Green, Mark (1996b), Compromising Your Drug of Choice: How HMOs are Dictating Your Next Prescription Office of the Public Advocate for the City of New York, New York.Google Scholar
  22. Green, Mark (1996a), What Ails HMOs Office of the Public Advocate for the City of New York.Google Scholar
  23. Hilts, Philip J. (1997), ‘Researcher Profited After Study by Investing in Cold Treatment’, New York Times, 1 February, p. A6.Google Scholar
  24. Hubbard, Ruth; Wald, Elijah (1993), Exploding the Gene Myth Beacon Press, Boston.Google Scholar
  25. Hudson, Kathy L.; Rothenberg, Karen H.; Andrews, Lori B.; Kahn, Mary Jo Ellis; Collins, Francis S. (1995), ‘Genetic Discrimination and Health Insurance: An Urgent Need for Reform’, Science, Vol. 270, pp. 391–393.PubMedCrossRefGoogle Scholar
  26. Huggins, Marlene; Bloch, Maurice; Kanani, Shelin; Quarrell, Oliver W.J.; Theilman, Jane; Hedrick, Amy; Dickens, Bernard; Lynch, Abbyan; Hayden, Michael (1990), ‘Ethical and Legal Dilemmas Arising During Predictive Testing for Adult-Onset Disease: The Experience of Huntington Disease’, American Journal of Human Genetics, Vol. 47, pp. 4–12.PubMedGoogle Scholar
  27. Kolata, Gina (1995), ‘When Patients’ Records are Commodities for Sale’, New York Times, 15 November, pp. A1, C14.Google Scholar
  28. Kolata, Gina (1996), ‘Breaking Ranks, Lab Offers Test Assessing Cancer Risk’, New York Times, 1 April, p. A1.Google Scholar
  29. Koshland, Daniel (1989), ‘Sequences and Consequences of the Human Genome’, Science, Vol. 246, p. 189.PubMedCrossRefGoogle Scholar
  30. Kozal, Michael J.; Shah, Nila; Shen, Naiping; Yang, Robert; Fucini, Raymond; Merigan, Thomas C; Richman, Douglas D.; Morris, Don; Hubbell, Earl; Chee, Mark; Gingeras, Thomas R. (1996), ‘Extensive Polymorphisms Observed in HIV-1 Clade B Protease Gene Using High-Density Oligonucleotide Arrays’, Nature Medicine, Vol. 2,No. 7, pp. 753–759.PubMedCrossRefGoogle Scholar
  31. Lewontin, R.C. (1992), ‘The Dream of the Human Genome’, New York Review of Books, 19 November, pp. 31–40.Google Scholar
  32. Lockhart, D.J.; Dong, H.; Byrne, M.C.; Follettie, M.T.; Gallo, M.V.; Chee, M.S.; Mittmann, M.; Wang, C; Kobayashi, M.; Horton, H.; Brown, E.L. (1996), ‘Expression Monitoring by Hybridization to High-Density Oligonucleotide Arrays’, Nature Biotechnology, Vol. 14, pp. 1675–1680.PubMedCrossRefGoogle Scholar
  33. McNally, Ruth; Wheale, Peter (1996), ‘Biopatenting and Biodiversity’, The Ecologist, Vol. 26,No. 5, pp. 222–228.Google Scholar
  34. Nelkin, D.; Lindee, M.S. (1995) The DNA mystique: The gene as a cultural icon W. H. Freeman and Company, New York.Google Scholar
  35. OMIM (1996), Online Mendelian Inheritance in Man Center for Medical Genetics, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD); World Wide Web URL:
  36. Pease, A.C.; Solas, D.; Sullivan, E.J.; Cronin, M.T.; Holmes, C.P.; Fodor, S.P.A. (1994), ‘Light Generated OH-gonucleotide Arrays for Rapid DNA Sequence Analysis’, Proceedings of the National Academy of Sciences, Vol. 91, pp. 5022–5026.CrossRefGoogle Scholar
  37. Pokorski, R. (1994), ‘Use of Genetic Information by Private Insurers’ in Murphy, T.; Lappe, M. (eds.), Justice and the Human Genome Project University of California Press, Berkeley, pp. 91–109.Google Scholar
  38. Raab, Selwyn (1996), ‘N.J. Officials Say Mob Ring Infiltrated Health Care’, New York Times, 21 August, pp. A1, C19.Google Scholar
  39. Silverman, Paul H. (1995), ‘Commerce and Genetic Diagnostics’, Hastings Center Report, Vol. 25No. 3 Supplement, pp. S15–S18.CrossRefGoogle Scholar
  40. Stone, Richard (1993), ‘Biotech Sails into Heavy Financial Seas’, Science, Vol. 260,No. 5110, 14 May, pp. 908–910.PubMedCrossRefGoogle Scholar
  41. Task Force on Genetic Information and Insurance (1993), Genetic Information and Health Insurance: Report of the Task Force on Genetic Information and Health Insurance National Institutes of Health, Washington, D.C.Google Scholar
  42. Wade, Nicholas (1997), ‘Where Computers and Biology Meet: Making a DNA Chip’, New York Times, 8 April, p. C1.Google Scholar
  43. Wadman, M. (1996), ‘Drug Company’ suppressed’ Publication of Resaerch [news]’, Nature, Vol. 381,No. 6577, 2 May, p. 4.PubMedGoogle Scholar
  44. Watson, James D. (1990), ‘The Human Genome Project-Past, Present, and Future’, Science, Vol. 248, pp. 44–49.PubMedCrossRefGoogle Scholar
  45. Watson, James D. (1992), ‘A Personal View of the Project’ Kevles, in Daniel J.; Hood, Leroy (eds.), The Code of Codes: Scientific and Social Issues in the Human Genome Project Harvard University Press, Cambridge, pp. 164–176.Google Scholar

Copyright information

© Kluwer Academic/Plenum Publishers 1999

Authors and Affiliations

  • Curtis R. Naser
    • 1
  1. 1.Fairfield UniversityUSA

Personalised recommendations